Skip to main content
SpringerLink
Log in

Biological therapy-related hepatosplenic T-cell lymphoma

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Shah ED, et al. Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System. Alimentary Pharmacology and Therapeutics : 28 Jan 2020. Available from: URL: http://doi.org/10.1111/apt.15637

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Biological therapy-related hepatosplenic T-cell lymphoma. Reactions Weekly 1790, 6 (2020). https://doi.org/10.1007/s40278-020-74625-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-74625-z

Search

Navigation